| Financial Year |
March 31 2023 |
| Monetary Funds |
2,281,344,223.33 |
| Held-for-trading Financial Assets |
126,544.00 |
| Notes Receivable |
195,493.28 |
| Accounts Receivable |
1,126,503,393.53 |
| Advances to Suppliers |
36,793,889.41 |
| Other Receivables |
54,032,345.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,103,508.99 |
| Inventories |
62,233,825.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
215,475,536.15 |
| Total Current Assets |
3,783,089,988.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
604,361,689.49 |
| Investment Properties |
-- |
| Fixed Assetes |
18,302,078,932.75 |
| Under-construction Projects |
639,617,781.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
320,051,462.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,729,373.20 |
| Deferred Income Tax Assets |
1,022,908,965.35 |
| Other Non-Current Assets |
284,527,470.36 |
| Sub-Total of Non-Current Assets |
23,150,829,206.72 |
| Total Assets |
26,933,919,195.19 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,540,000.00 |
| Accounts Payable |
746,426,288.71 |
| Accounts Received In Advance |
49,868,118.15 |
| Employee Compensation Payable |
204,587,895.37 |
| Taxes Payable |
96,397,418.98 |
| Interest Payable |
-- |
| Dividend Payable |
12,677,428.45 |
| Other payables |
4,354,165,307.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
292,578,687.19 |
| Other Current Liabilities |
1,006,838,356.17 |
| Sub-Total of Current Liabilities |
6,817,152,159.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
325,529,181.49 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,354,724.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,658,953,177.79 |
| Total Liabilities |
9,476,105,336.85 |
| Paid-In Capital(Or Share Stock) |
2,366,718,283.00 |
| Capital Surplus |
9,902,447,776.47 |
| Surplus Reserve |
887,689,603.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,057,427,891.69 |
| Minority Stockholder's Interest |
224,522,808.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,233,291,049.97 |
| Owner's Equity（Stockholder's Equity） |
17,457,813,858.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,933,919,195.19 |
